Orchestra BioMed Holdings, Inc. (OBIO)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, Orchestra BioMed Holdings, Inc. reported revenue of $33.48M, up 1169.2% from the prior year. The company ran a net loss, with a net margin of -157.4%. It held $114.86M in total assets against $51.48M in total liabilities.
Key ratios (FY2025)
-154.7%
Operating margin
-157.4%
Net margin
-98.4%
Return on equity
+1169.2%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Revenue | $33.48M | $2.64M | $2.76M | $3.53M | — | — |
| Cost of Revenue | $190.0K | $204.0K | $186.0K | $211.0K | — | — |
| Operating Income | -$51.81M | -$64.30M | -$51.51M | -$32.66M | -$394.8K | — |
| Net Income | -$52.70M | -$61.02M | -$49.12M | -$33.61M | -$378.8K | — |
| EPS (Diluted) | $-1.11 | $-1.66 | $-1.48 | $-2.24 | $-0.02 | — |
| Total Assets | $114.86M | $76.17M | $95.21M | $95.57M | $161.82M | $162.16M |
| Total Liabilities | $51.48M | $43.22M | $27.17M | $43.04M | $5.77M | $5.72M |
| Shareholders' Equity | $53.57M | $32.96M | $68.04M | $52.53M | -$19.78M | -$3.56M |
| Cash & Equivalents | $34.69M | $22.26M | $30.56M | $19.78M | $1.75M | $2.03M |
| Operating Cash Flow | -$48.96M | -$50.56M | -$46.13M | -$29.29M | -$272.4K | — |
| Capital Expenditures | $489.0K | $289.0K | $78.0K | $591.0K | — | — |
| Shares Outstanding | 57.03M | 38.19M | 35.78M | 20.19M | 4.45M | 4.45M |